Skip to main content
. 2023 Apr 17;8(3):101213. doi: 10.1016/j.esmoop.2023.101213

Figure 2.

Figure 2

Progression-free survival (time from diagnosis of BM to progress of BM, 25 ECM or death) in the overall cohort according to tumor subtypes.

BM, brain metastases; TNBC, triple-negative breast cancer.